Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 2;10(1):188.
doi: 10.1186/s13104-017-2511-2.

High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control

Fatima-Zahra Laarabi  1   2 , Ilham Ratbi  1 , Siham Chafai Elalaoui  1   2 , Loubna Mezzouar  3 , Yassamine Doubaj  1   2 , Laila Bouguenouch  4 , Karim Ouldim  4 , Noureddine Benjaafar  5 , Abdelaziz Sefiani  6   7
Affiliations

High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control

Fatima-Zahra Laarabi et al. BMC Res Notes. .

Abstract

Background: To date, a limited number of BRCA1/2 germline mutations have been reported in hereditary breast and/or ovarian cancer in the Moroccan population. Less than 20 different mutations of these two genes have been identified in Moroccan patients, and recently we reported a further BRCA2 mutation (c.1310_1313delAAGA; p.Lys437IlefsX22) in three unrelated patients, all from the North-East of the country. We aimed in this study to evaluate the frequency and geographic distribution of this BRCA2 frameshift mutation, in order to access its use as the first-line BRCA genetic testing strategy for Moroccan patients. We enrolled in this study 122 patients from different regions of Morocco, with suggestive inherited predisposition to breast and ovarian cancers. All subjects gave written informed consent to BRCA1/2 genetic testing. According to available resources of our lab and enrolled families, 51 patients were analyzed by the conventional individual exon-by-exon Sanger sequencing, 23 patients were able to benefit from a BRCA next generation sequencing and a target screening for exon 10 of BRCA2 gene was performed in 48 patients.

Results: Overall, and among the 122 patients analyzed for at least the exon 10 of the BRCA2 gene, the c.1310_1313delAAGA frameshift mutation was found in 14 patients. Genealogic investigation revealed that all carriers of this mutation shared the same geographic origin and were descendants of the North-East of Morocco.

Discussion: In this study, we highlighted that c.1310_1313delAAGA mutation of BRCA2 gene is recurrent with high frequency in patients from the North-East region of Morocco. Therefore, we propose to use, in public health strategies, the detection of this mutation as the first-line screening tests in patients with breast and ovarian cancer originated from this region.

Keywords: BRCA2; Breast cancer; North-East Morocco; Recurrent mutation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Map of Morocco showing the geographic origin of the 14 patients carrying the c.1310_1313delAAGA mutation. It reveals the concentration of patients in the North-East of Morocco
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Willems PG. Susceptibility genes in breast cancer: more is less? Clin Genet. 2007;72:493–496. doi: 10.1111/j.1399-0004.2007.00909.x. - DOI
    1. Lynch HT, Albano WA, Danes BS, Layton MA, Kimberling WJ, Lynch JF, et al. Genetic predisposition to breast cancer. Cancer. 1984;53:612–622. doi: 10.1002/1097-0142(19840201)53:3+<612::AID-CNCR2820531306>3.0.CO;2-5. - DOI - PubMed
    1. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77:2318–2324. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z. - DOI - PubMed
    1. Robson ME, Boyd J, Borgen PI, Cody HS., III Hereditary breast cancer. Curr Probl Surg. 2001;38:387–480. doi: 10.1016/S0011-3840(01)70035-4. - DOI - PubMed
    1. Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Instit. 2006;98:1694–1706. doi: 10.1093/jnci/djj465. - DOI - PubMed

Supplementary concepts